Attenuated effectiveness of tumor necrosis factor inhibitors for anti ‐human T‐lymphotropic virus type 1 antibody‐positive rheumatoid arthritis

ConclusionsThe efficacy of TNF inhibitors may be attenuated in RA patients with positive anti‐HTLV‐I antibody. ATL and HAM did not develop when TNF inhibitors were used for 24 weeks, but the long‐term risk is not known.This article is protected by copyright. All rights reserved.

Source: Arthritis and Rheumatism - February 22, 2018 Category: Rheumatology Authors: Takahisa Suzuki, Shoichi Fukui, Kunihiko Umekita, Junya Miyamoto, Masataka Umeda, Ayako Nishino, Akitomo Okada, Tomohiro Koga, Shin ‐ya Kawashiri, Naoki Iwamoto, Kunihiro Ichinose, Mami Tamai, Keita Fujikawa, Toshiyuki Aramaki, Akinari Mizokami, Naoki M Tags: Brief Report Source Type: research